Skip to main content

Table 4 Antibiotic susceptibility profiles of VS isolates from VS peritonitis episodes in patients undergoing peritoneal dialysis

From: Viridans streptococcus peritonitis in peritoneal dialysis: clinical characteristics and comparison with concurrent polymicrobial infection

Tested antibiotic VS isolates in mono-VS peritonitis, no./No. (%) VS isolates in mixed-VS peritonitis, no./No. (%) P
Susceptible Non-susceptible Susceptible Non-susceptible
Recent antibiotic exposure (A) Prior peritonitis (B) Recent antibiotic exposure (C) Prior peritonitis (D) Recent antibiotic exposure (E) Prior peritonitis (F) Recent antibiotic exposure (G) Prior peritonitis (H) A vs. C B vs. D E vs. G F vs. H A vs. E B vs. F
Ampicillin 11/73 (15.1) 37/73 (50.7) 1/5 (20.0) 3/5 (60.0) 3/28 (10.7) 19/28 (67.9) 1/3 (33.3) 3/3 (100.0) 0.577 1.000 0.349 0.537 0.806 0.120
Clindamycin 10/67 (15.0) 34/67 (50.7) 2/11 (18.2) 6/11 (54.5) 4/29 (13.8) 20/29 (69.0) 0/2 (0.0) 2/2 (100.0) 1.000 0.815 1.000 1.000 1.000 0.098
Ceftriaxone 8/62 (13.0) 30/62 (48.4) 2/6 (33.3) 4/6 (66.7) 1/27 (3.7) 18/27 (66.7) 3/4 (75.0) 4/4 (100.0) 0.212 0.669 0.003 0.295 0.347 0.112
Erythromycin 8/57 (14.0) 27/57 (47.4) 4/21 (19.0) 13/21 (61.9) 3/26 (11.5) 18/26 (69.2) 1/5 (20.0) 4/5 (80.0) 0.849 0.255 0.525 1.000 1.000 0.064
Penicillin 10/71 (14.1) 36/71 (50.7) 2/7 (28.6) 4/7 (57.1) 3/27 (11.1) 18/27 (66.7) 1/4 (25.0) 4/4 (100.0) 0.642 1.000 0.442 0.435 0.957 0.156
Teicoplanin 12/74 (16.2) 39/74 (52.7) 0/0 (0.0) 0/0 (0.0) 4/29 (13.8) 22/29 (75.9) 0/0 (0.0) 0/0 (0.0) 0.998 0.031
Vancomycin 11/66 (16.7) 33/66 (50.0) 0/0 (0.0) 0/0 (0.0) 4/31 (12.9) 22/31 (71.0) 0/0 (0.0) 0/0 (0.0) 0.860 0.052
  1. no./No. = number of VS isolate(s) with recent antibiotic exposure or prior PD-peritonitis/number of VS isolates subject to antibiotic susceptibility testing